A case of porphyria cutanea terda (PCT) occurring after bone marrow transplantation (BMT) is reported. A 43-year-oid male with chronic myelogenous leukemia received an human leukocyte antigen (HLA)-identical allogeneic transplantation with T-cell depleted marrow. Because of graft rejection, a second
Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia
β Scribed by Khoury, H; Adkins, D; Zehnbauer, B; Goodnough, L; Brown, R; Safdar, S; DiPersio, J F
- Book ID
- 110010606
- Publisher
- Nature Publishing Group
- Year
- 1998
- Tongue
- English
- Weight
- 29 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow tran
## Abstract In previously published studies on patients with juvenile chronic myelogenous leukemia (JCML), excessive proliferation of malignant monocyteβmacrophage elements and impaired growth of normal hematopoietic progenitors were demonstrated. A selective hypersentivity of granulocytemachrophag